Wall Street slips on tech sector weakness
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall St futures muted as US-Iran impasse lifts oil prices
- JPMorgan lifts S&P 500 target to 8,000 on strong earnings
- Nvidia and Wall Street giants plan $500B AI funding deal, FT reports
- Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
Apple (AAPL) PT Maintained at $195 at Wells Fargo; 'China Mobile Phone Export Data Reinforces Cautious Opinion on iPhone Cycle'
December 28, 2017 5:58 AM ESTWells Fargo maintained its price target on Apple (NASDAQ: AAPL) at $195.00 while maintaining a Market Perform rating, following a review of the company's iPhone-related data out of China.
Analyst Aaron Rakers notes a cautious outlook on the company's iPhone cycle in China, citing mobile phone export data out this week that... More
Sucampo Pharma (SCMP) Ticks Above Takeover Price
December 26, 2017 12:48 PM ESTSucampo Pharma (NASDAQ: SCMP) has ticked above Mallinckrodt's $18 per share acquisition price. SCMP last at $18.05. Speculators cite the relatively low $44 million break-up fee.
... MoreMallinckrodt's (MNK) Sucampo Acquisition 'Is A Smart Strategic Deal' - Cantor Fitzgerald
December 26, 2017 11:42 AM ESTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $42 price target on Mallinckrodt plc (NYSE: MNK) following the strategic deal to acquire Sucampo (NASDAQ: SCMP) for $1.2 billion.
Chen said she likes the deal because it brings a... More
Maxim Group Downgrades Sucampo Pharmaceuticals (SCMP) to Hold Following Acquisition; Sees Low Probability of Another Bidder
December 26, 2017 10:46 AM ESTMaxim Group downgraded Sucampo Pharmaceuticals (NASDAQ: SCMP) from Buy to Hold after the company agreed to be acquired.
"We understand there is a nominal breakup fee which leaves the door open for another bidder, though we see this as low probability," analyst Jason... More
Sucampo Pharma (SCMP) Discloses $44M Merger Termination Fee
December 26, 2017 7:57 AM ESTSucampo Pharma (NASDAQ: SCMP) disclosed that it will pay Mallinckrodt (NYSE: MNK) a termination fee of $44 million if it terminates the merger agreement, including a termination by Sucampo to enter into an agreement for an alternative transaction that constitutes a "Superior Offer."
... More